Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Expression and function of Kv1.3 channel in malignant T cells in Sézary syndrome

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Adoptive cell therapy in combination with checkpoint inhibitors in ovarian cancer

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Correction: Calcium electroporation for treatment of sarcoma in preclinical studies

    Research output: Contribution to journalJournal articleResearch

  3. Real-world evidence to guide healthcare policies in oncology

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Lynch syndrome-associated epithelial ovarian cancer and its immunological profile

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. The capacity of CD4+ Vγ9Vδ2 T cells to kill cancer cells correlates with co-expression of CD56

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Vγ9Vδ2 T Cells Concurrently Kill Cancer Cells and Cross-Present Tumor Antigens

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. ABO blood types and sepsis mortality

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

The voltage-gated potassium channel Kv1.3 (KCNA3) is expressed by a subset of chronically activated memory T cells and plays an important role in their activation and proliferation. Here, we show that primary malignant T cells isolated from patients with Sézary syndrome (SS) express Kv1.3 and are sensitive to potent Kv1.3 inhibitors ShK and Vm24, but not sensitive to a less potent inhibitor [N17A/F32T]-AnTx. Kv1.3 blockade inhibits CD3/CD28-induced proliferation and IL-9 expression by SS cells in a concentration-dependent manner. In parallel, CD3/CD28-mediated CD25 induction is inhibited, whereas Kv1.3 blockade has no effect on apoptosis or cell death as judged by Annexin V and PI staining. In conclusion, we provide the first evidence that malignant T cells in SS express functional Kv1.3 channels and that Kv1.3 blockade inhibits activation-induced proliferation as well as cytokine and cytokine receptor expression in malignant T cells, suggesting that Kv1.3 is a potential target for therapy in SS.

Original languageEnglish
JournalOncotarget
Volume10
Issue number47
Pages (from-to)4894-4906
Number of pages13
ISSN1949-2553
DOIs
Publication statusPublished - 6 Aug 2019

ID: 58521676